Latest News and Press Releases
Want to stay updated on the latest news?
-
Third quarter GAAP net sales of $1.13 billion, an increase of 11% year-over-year; non-GAAP organic net sales increased 12% year-over-year Third quarter GAAP net loss of $35 million; third quarter...
-
PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results...
-
Second quarter GAAP net sales of $1.03 billion, an increase of 2% year-over-year; non-GAAP organic net sales increased 5% year-over-year Second quarter GAAP net income of $54 million, including a $70...
-
PORTLAND, Maine, July 28, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2020 results...
-
PORTLAND, Maine, June 25, 2020 (GLOBE NEWSWIRE) -- Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, announced today its board of directors has declared a quarterly...
-
First quarter GAAP net sales of $1.07 billion, an increase of 13% year-over-year; non-GAAP pro forma organic net sales increased 10% year-over-year First quarter GAAP net loss of $33 million as...
-
PORTLAND, Maine, May 05, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release first quarter 2020 financial...
-
PORTLAND, Maine, April 30, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today a $250 million investment from Clayton,...
-
Operationally, all of the company's distribution centers and pharmacies currently remain open, as veterinary medicine has been deemed an essential service in most geographies around the...
-
Board of directors announces acting chief executive officer Benjamin Wolin to serve as president and CEO Fourth quarter net sales of $1.0 billion, an increase of 12% year-over-year; non-GAAP pro forma...